Anticoagulation postablation

Links shared publicly online about this topic.

  • 1,370
    total visits

Anticoagulation postablation

theheart.org

Despite the positive findings, an editorial calls the study hypothesis-generating, noting that the AF field needs a prospective randomized clinical trial, one that includes standardized methods to assess and characterize recurrence of AF and to determine the incidence/prevalence of stroke.

View full resource at theheart.org

Tags: Stroke, Thrombotic Event, Clinical Trial, Anti-Clotting Medication, Anticoagulant, Coumadin

  • Share

Most Recently Shared on February 19, 2010 at 4:32 pm By:

theheartorg Shelley Wood

Warfarin can be stopped at three to six months postablation of AF, but editorial urges caution: Despite the positi... http://bit.ly/azRe7A

2 years ago...

Review of the Managing Dabigatran App from ObsHealth for iPhone/iPad

imedicalapps.com — “Review of the Managing Dabigatran App, to Assist Healthcare Providers with the Prescribing and Managing of Pradaxa (Dabigatran)View full resource at imedicalapps.com

  • View Related
  • Share

Most Recently Shared on April 17, 2012 at 2:55 pm By:

iMedicalApps iMedicalApps.com

New app helps clinicians manage new anticoagulant Pradaxa (Dabigatran) http://t.co/OYAv4Pdj

2 weeks ago...

JACC: 10 points to remember on oral anticoagulants in #AFib and ACS

cardiosource.org — “JACC: 10 points to remember on oral anticoagulants in #AFib and ACSView full resource at cardiosource.org

  • View Related
  • Share

Most Recently Shared on April 9, 2012 at 11:00 pm By:

ACCinTouch AmerColl Cardiology Cardiology and Medical Society

JACC: 10 points to remember on oral anticoagulants in #AFib and ACS http://t.co/FAHSo9lF

3 weeks ago...

ACP Internist, April 2012 - New drugs could improve anticoagulation rates

acpinternist.org — “ACP Internist, April 2012 - New drugs could improve anticoagulation ratesView full resource at acpinternist.org

  • View Related
  • Share

Most Recently Shared on April 5, 2012 at 12:05 pm By:

theheart.org: trusted cardiology news and opinions

theheart.org — “The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on March 28, 2012 at 2:51 am By:

theheart.org: trusted cardiology news and opinions

theheart.org — “The latest developments in cardiology and cardiovascular research, including heartwire news and commentary by some of the world's top cardiologists. Sign up for free.View full resource at theheart.org

  • View Related
  • Share

Most Recently Shared on March 27, 2012 at 7:56 pm By:

theheartorg Shelley Wood Cardiology

New oral anticoagulants in AF: What to do in clinical practice http://t.co/dRIaE4ER #ACC12

1 month ago...

New Designer Drugs for Stroke Prevention in Atrial Fibrillation Patients : Healthymagination

healthymagination.com — “Three new game-changing anticoagulants have been developed for the prevention of strokes in people with atrial fibrillation. The new designer drugs dabigatran, rivaroxaban and apixaban offer significant benefits compared to decades-old warfarin, but there are some downsides to consider.View full resource at healthymagination.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 4:45 pm By:

HerpesLine Herpes on Healthline Health Site

New designer drugs for people suffering with atrial fibrillation: http://t.co/n5MnEwEj

1 month ago...

CardioSmart: Your Inside Scoop on the 2012 Convention of the World's Heart Experts

cardiosmart.org — “CardioSmart: Your Inside Scoop on the 2012 Convention of the World's Heart ExpertsView full resource at cardiosmart.org

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 3:58 pm By:

CardioSmart CardioSmart Health Organization

Get the inside scoop! CardioSmart Patient Correspondant reports from #ACC12. Watch interviews w/ top heart experts http://t.co/kphdSX1i

1 month ago...

Novel drug in pill form safer than standard approach to treat blocked lung blood vessels

medicalxpress.com — “A novel oral anti-coagulant outperformed the injected standard therapy on important safety measures for initial and long-term treatment of pulmonary embolism – a blockage of lung blood vessels usually caused by a clot – and showed comparable efficacy, according to data from the EINSTEIN-PE ...View full resource at medicalxpress.com

  • View Related
  • Share

Most Recently Shared on March 26, 2012 at 3:30 pm By:

physorg_health PhysOrg Health News Health News

Novel drug in pill form safer than standard approach to treat blocked lung blood vessels http://t.co/tyxObO6R

1 month ago...

Infusion of drug into the coronary artery may help reduce size of heart damage after heart attack

medicalxpress.com — “Administration of a bolus dose of the anticoagulant drug abciximab into the coronary artery involved in causing a certain type of heart attack among patients who were undergoing a percutaneous coronary intervention and also receiving another anticoagulant resulted in reduction in the size of damage ...View full resource at medicalxpress.com

  • View Related
  • Share

Most Recently Shared on March 25, 2012 at 8:27 pm By:

physorg_health PhysOrg Health News Health News

Infusion of drug into the coronary artery may help reduce size of heart damage after heart attack http://t.co/mUSgd5Lw

1 month ago...

Drug Infusion Into Coronary Artery May Help Reduce Size of Heart Damage After Heart Attack

newswise.com — “Administration of a bolus dose of the anticoagulant drug abciximab into the coronary artery involved in causing a certain type of heart attack among patients who were undergoing a PCI and also receiving another anticoagulant resulted in reduction in the size of damage to the heart muscle.View full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on March 25, 2012 at 1:49 pm By:

mednewswise Thom Canalichio Health News

#health news: Drug Infusion Into Coronary Artery May Help Reduce Size of Heart Damage After Heart Attack http://t.co/EFrwVxAr

1 month ago...

Drug Infusion Into Coronary Artery May Help Reduce Size of Heart Damage After Heart Attack

newswise.com — “Administration of a bolus dose of the anticoagulant drug abciximab into the coronary artery involved in causing a certain type of heart attack among patients who were undergoing a PCI and also receiving another anticoagulant resulted in reduction in the size of damage to the heart muscle.View full resource at newswise.com

  • View Related
  • Share

Most Recently Shared on March 25, 2012 at 1:28 pm By:

newswise newswise Health Communicator and Health News

Drug Infusion Into Coronary Artery May Help Reduce Size of Heart Damage After Heart Attack http://t.co/n9GdRzYW

1 month ago...

Medical News:Debris Prompts Anticoagulant Recall - in Public Health & Policy, FDA General from MedPage Today

medpagetoday.com — “Medical News:Debris Prompts Anticoagulant Recall - in Public Health & Policy, FDA General from MedPage TodayView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 7:52 pm By:

MedicalFeed MedicalFeed Health News Feed

Debris Prompts Anticoagulant Recall: (MedPage Today) -- The maker of an argatroban 50 mg/50… http://t.co/GPq2tEPD

1 month ago...

Debris Prompts Anticoagulant Recall - QualityPoint Technologies

qualitypointtech.net — “(MedPage Today) -- The maker of an argatroban 50 mg/50 mL injection has recalled four lots of the product because of visible particles in the solution.View full resource at qualitypointtech.net

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 6:45 pm By:

MedicalFeed MedicalFeed Health News Feed

Debris Prompts Anticoagulant Recall: (MedPage Today) -- The maker of an argatroban 50 mg/50 mL injection has recal... http://t.co/qUYeyR52

1 month ago...

Medical News:Debris Prompts Anticoagulant Recall - in Public Health & Policy, FDA General from MedPage Today

medpagetoday.com — “Medical News:Debris Prompts Anticoagulant Recall - in Public Health & Policy, FDA General from MedPage TodayView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on March 24, 2012 at 6:36 pm By:

Medical News:Afib, Stroke, and the New Anticoagulants, a Roundtable - in Cardiovascular, Strokes from MedPage Today

medpagetoday.com — “Medical News:Afib, Stroke, and the New Anticoagulants, a Roundtable - in Cardiovascular, Strokes from MedPage TodayView full resource at medpagetoday.com

  • View Related
  • Share

Most Recently Shared on March 22, 2012 at 10:40 pm By:

Advertisement